We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$51.4B
AUM Growth
+$1.46B
Cap. Flow
+$987M
Cap. Flow %
1.92%
Top 10 Hldgs %
18.85%
Holding
2,686
New
375
Increased
1,038
Reduced
898
Closed
357

Top Buys

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$512M
2
AMD icon
Advanced Micro Devices
AMD
+$401M
3
RBLX icon
Roblox
RBLX
+$384M
4
TSM icon
TSMC
TSM
+$371M
5
TJX icon
TJX Companies
TJX
+$271M

Sector Composition

Rank Sector Weight
1 Technology 27.47%
2 Consumer Discretionary 14.55%
3 Financials 14.39%
4 Healthcare 12.45%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIC icon
1926
Nicolet Bankshares
NIC
$3.57B
$352K ﹤0.01%
+2,900
New +$367K
NOV icon
1927
NOV
NOV
$7.45B
$352K ﹤0.01%
22,500
-59,000
-72% -$875K
ALEX
1928
DELISTED
Alexander & Baldwin
ALEX
$351K ﹤0.01%
17,000
-30,700
-64% -$533K
LMB icon
1929
Limbach Holdings
LMB
$867M
$350K ﹤0.01%
4,500
-2,700
-38% -$222K
ES icon
1930
Eversource Energy
ES
$28.2B
$350K ﹤0.01%
5,200
+1,500
+41% +$105K
OPRA
1931
Opera Ltd
OPRA
$1.65B
$348K ﹤0.01%
24,600
-7,700
-24% -$114K
MAX icon
1932
MediaAlpha
MAX
$710M
$348K ﹤0.01%
26,896
+6,496
+32% +$79.3K
DTIL icon
1933
Precision BioSciences
DTIL
$188M
$347K ﹤0.01%
83,443
+31,419
+60% +$178K
FSK icon
1934
FS KKR Capital
FSK
$2.98B
$346K ﹤0.01%
23,389
-21,300
-48% -$323K
FULC icon
1935
Fulcrum Therapeutics
FULC
$248M
$345K ﹤0.01%
30,500
-1,000
-3% -$10.2K
EBC icon
1936
Eastern Bankshares
EBC
$5.25B
$345K ﹤0.01%
18,700
-2,700
-13% -$49.4K
MDXG icon
1937
MiMedx Group
MDXG
$626M
$344K ﹤0.01%
50,800
+28,300
+126% +$198K
AARD
1938
Aardvark Therapeutics
AARD
$138M
$344K ﹤0.01%
26,200
+500
+2% +$6.24K
BHRB icon
1939
Burke & Herbert Financial Services Corp
BHRB
$1.42B
$344K ﹤0.01%
5,516
-4,600
-45% -$288K
RENT
1940
Rent the Runway
RENT
$101M
$340K ﹤0.01%
42,998
+27,028
+169% +$146K
LRMR icon
1941
Larimar Therapeutics
LRMR
$416M
$340K ﹤0.01%
89,124
-163,247
-65% -$635K
LILAK icon
1942
Liberty Latin America Class C
LILAK
$1.5B
$339K ﹤0.01%
50,050
+8,030
+19% +$60.1K
CALY
1943
Callaway Golf Company
CALY
$3.26B
$337K ﹤0.01%
28,900
+8,900
+45% +$93.9K
PLMR icon
1944
Palomar
PLMR
$3.65B
$337K ﹤0.01%
2,500
+300
+14% +$36.6K
MKSI icon
1945
MKS Inc
MKSI
$22.2B
$336K ﹤0.01%
+2,100
New +$312K
RMAX icon
1946
RE/MAX Holdings
RMAX
$200M
$335K ﹤0.01%
44,200
+10,600
+32% +$86K
MANU icon
1947
Manchester United
MANU
$3.91B
$334K ﹤0.01%
+21,000
New +$339K
PHR icon
1948
Phreesia
PHR
$632M
$333K ﹤0.01%
19,700
+900
+5% +$18.6K
ATI icon
1949
ATI
ATI
$27B
$333K ﹤0.01%
+2,900
New +$283K
GTE icon
1950
Gran Tierra Energy
GTE
$260M
$332K ﹤0.01%
78,352
+23,331
+42% +$98.4K

Similar funds

Two Sigma Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, Two Sigma Advisers held 2,686 positions worth $51.4B, up 2.9% from $50B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Two Sigma Advisers's Q4 2025 filing shows 375 new, 1,038 increased, 898 reduced and 357 closed positions. Its largest new stake was Kimberly-Clark: 2,442,100 shares worth $246M. The largest sale was Bank of America, an estimated $569M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Two Sigma Advisers's largest Q4 2025 buy was Kimberly-Clark: 2,442,100 shares worth $246M.
  • Two Sigma Advisers added most to ServiceNow in Q4 2025, an estimated $512M increase.
  • Two Sigma Advisers's biggest Q4 2025 reduction was Bank of America, cutting an estimated $569M.
  • Two Sigma Advisers fully exited Nebius Group N.V. in Q4 2025, selling an estimated $257M.
  • Two Sigma Advisers's ten largest holdings make up 19% of its $51.4B portfolio in Q4 2025.
  • Two Sigma Advisers opened 375 new positions and closed 357 in Q4 2025.
  • Two Sigma Advisers's portfolio value rose 2.9% quarter-over-quarter to $51.4B.

Based on Two Sigma Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.